• About
    • Advisory Board
    • Network Organisation
    • News archive
  • Consortium
  • Projects
    • Project 1 (UWr)
    • Project 11 (UWr)
    • Project 2 (UoB)
    • Project 3 (BGU)
    • Project 4 (USC)
    • Project 5 (MUV)
    • Project 6 (MUV)
    • Project 7 (TG)
    • Project 8 (UoW)
    • Project 9 (MUW)
    • Project 10 (TCD)
  • Fellows
  • Training
Official project start

Official project start

by frt_admin_erad | Jan 1, 2024 | Uncategorized

The eRaDicate project has officially started on the 1st of January 2024 and will run for 4 years until the 31st of December 2027. about...
Next Entries »

Recent Posts

  • Bringing Biotechnology to Life: Hands-On Workshop for Students
  • eRaDicate’s participation in the Long Night of Research
  • Agnes Graf’s secondment to Physiolution
  • Advancing the frontiers of breast cancer research – L. Avila et al.
  • eRaDicate webinar and keynote on cancer stem cells hosted by TissueGnostics GmbH

Recent Comments

No comments to show.

Developing innovative ligands for Nuclear Receptors to Eradicate Cancer Relapse

About

Consortium

Projects

Fellows

Training

File Hub

Coordinator

Priv.-Doz. Mag. Dr. Martin Schepelmann
(Medical University of Vienna, Austria)
martin.schepelmann@meduniwien.ac.at

Co-Chair

Prof. Andrzej Kutner
(Medical University of Warsaw, Poland)

Project Management

Priv.-Doz. Mag. Dr. Enikö Kallay
(Medical University of Vienna, Austria)
enikoe.kallay@meduniwien.ac.at

Legal Notice Privacy Policy

© 2024

eRaDicate is a Marie Sklodowska Curie Actions Doctoral Network funded by the European Union (Project Number 101119427).